Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

NCT01396070

Conditions: Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients

NCT01228461

Conditions: Fatigue, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT01325701

Conditions: Diffuse Large Cell B-lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: UCLA Medical Center Los Angeles, California, United States

Stanford University School of Medicine Stanford, California, United States

National Cancer Institute Bethesda, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

View all 15 locations

View Trial Details

Completed

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

NCT02278510

Conditions: Glioma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

NCT03087929

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

NCT00097565

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Completed

Long-term Study Of Ropinirole In Restless Legs Syndrome

NCT00329602

Conditions: Dyssomnias, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: GSK Investigational Site Camperdown, New South Wales, Australia

GSK Investigational Site Kippa-Ring, Queensland, Australia

GSK Investigational Site Woodville, South Australia, Australia

GSK Investigational Site Clayton, Victoria, Australia

View all 39 locations

View Trial Details

Completed

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

NCT01900509

Conditions: Acute Leukemia, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

NCT02788916

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Santiago de Compostela, A Coruna, Spain

Barcelona, Spain

Santander, Cantabria, Spain

Córdoba, Cordoba, Spain

View Trial Details

Completed

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Research Site Calgary, Alberta, Canada

Research Site Surrey, British Columbia, Canada

Research Site Vancouver, British Columbia, Canada

Research Site Winnipeg, Manitoba, Canada

View all 24 locations

View Trial Details